I had trouble finding the previous numbers (Found it here)
Guidance;
Revenue (FY18): $27.6 - $29.5
Revenue (FY19): $26.6 - $28.5
EBITDA (FY18): $10.1 - $10.6
EBITDA (FY19): $8.7 - $9.4
So guidance for revenue down $1.0b on FY18, EBITDA down $1.2-$1.4
I expect the market will take it hard because unexpected bad news, but it could also be that this change was inevitable and its just coming faster than expected, so might not change anything for long term outlook (5y+)
- Forums
- ASX - By Stock
- TLS
- Ann: Telstra2022
Ann: Telstra2022, page-6
-
- There are more pages in this discussion • 70 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TLS (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.86 |
Change
-0.020(0.52%) |
Mkt cap ! $44.71B |
Open | High | Low | Value | Volume |
$3.89 | $3.90 | $3.85 | $32.49M | 8.394M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
69 | 398263 | $3.86 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.87 | 243091 | 70 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
69 | 398263 | 3.860 |
72 | 722843 | 3.850 |
40 | 548916 | 3.840 |
56 | 523407 | 3.830 |
48 | 352311 | 3.820 |
Price($) | Vol. | No. |
---|---|---|
3.870 | 243091 | 70 |
3.880 | 535987 | 31 |
3.890 | 792407 | 34 |
3.900 | 591678 | 84 |
3.910 | 326567 | 26 |
Last trade - 15.56pm 10/10/2024 (20 minute delay) ? |
Featured News
TLS (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online